US Business

With the boom in renewable energy, many of the credits that trade hands merely represent a transfer of money from one profitable enterprise to another, critics say.

The breakup of Ernst & Young’s auditing and consulting businesses will generate windfalls for the firm’s partners if successful.

Analysts say the drug, from Revance Therapeutics, poses a threat to the market-dominating antiwrinkle treatment because it promises to last longer.

Apple’s latest iPhones drew favorable interest in China after it decided not to raise some prices, but the company faces challenges in one of its most important markets from local rivals.

Delaware Chancery Court Chancellor Kathaleen McCormick heard arguments on several issues, including whether allegations from a whistleblower complaint can be added to the billionaire’s countersuit.

The deal between Sitio Royalties and Brigham Minerals is one of largest in the oil-and-gas industry this year.

The European Union’s antitrust regulator says the acquisition of Grail would stifle innovation and reduce choice in the blood-test market, putting a $7.1 billion merger into jeopardy after a U.S. judge allowed it to proceed.

The struggling home-goods retailer named Laura Crossen to lead its finances, a move aimed at reassuring investors after the death by suicide of CFO Gustavo Arnal.

The settlement with more than 30 states is the latest step by the e-cigarette maker to resolve allegations that it marketed its products to underage users.

Porsche shares could be trading by the end of September or early October.